SCICLONE PHARMACEUTICALS INC Research and Development Expense
SCICLONE PHARMACEUTICALS INC reported Research and Development Expense of $0 for the 3-month period ending 2015-09-30, per its 10-Q filed 2015-11-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2015-11-09
- SCICLONE PHARMACEUTICALS INC research and development expense for the quarter ending 2015-09-30 was $0.00.
- SCICLONE PHARMACEUTICALS INC research and development expense for the quarter ending 2015-06-30 was $5.50M.
- SCICLONE PHARMACEUTICALS INC research and development expense for the quarter ending 2014-09-30 was $0.00.
- SCICLONE PHARMACEUTICALS INC research and development expense for the quarter ending 2014-06-30 was $0.00.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month |
|---|---|---|---|
| 2015-09-30 | $0.00 10-Q · filed 2015-11-09 | $5.50M derived: sum of 2 quarters · filed 2015-11-09 | $5.50M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $5.50M 10-Q · filed 2015-08-10 | $5.50M 10-Q · filed 2015-08-10 | |
| 2014-09-30 | $0.00 10-Q · filed 2015-11-09 | $0.00 derived: sum of 2 quarters · filed 2015-11-09 | $0.00 10-Q · filed 2015-11-09 |
| 2014-06-30 | $0.00 10-Q · filed 2015-08-10 | $0.00 10-Q · filed 2015-08-10 |